AlphaMadera's AlphaVal page computes StoneX Group Inc.'s fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag SNEX as undervalued, fairly valued, or overvalued.

What is StoneX Group Inc.'s fair value?

Fair value for SNEX is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value SNEX?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from SNEX's most recent reported fundamentals.

SNEX - StoneX Group Inc.

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $112.00 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

AlphaVal Unavailable

AlphaVal: SNEX revenue per share ($1,114) is 15x the stock price ($74.26). Financials likely reported in a foreign currency.